Profile
Sector:
HealthcareIndustry:
Health Information ServicesCountry:
United StatesIPO:
28 November 2007Website:
http://www.optimizerx.comNext earnings report:
28 March 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 20 Nov 2024 21:02:14 GMTDividend
Analysts recommendations
Institutional Ownership
OPRX Latest News
OptimizeRx (OPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
The availability of Micro-Neighborhood ® Targeting on the Company's Dynamic Audience Activation Platform meets the demand of life sciences marketers by synchronizing consumer and physician marketing
OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.01 per share a year ago.
WALTHAM, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conference call on Thursday, August 8, 2024, at 4:30 p.m. Eastern Time to discuss its results for the second quarter period ended June 30, 2024. The financial results will be issued in a press release prior to the call.
The Company's AI-guided predictive targeting platform delivered three times the return in half the time of the traditional trigger-based program The Company's AI-guided predictive targeting platform delivered three times the return in half the time of the traditional trigger-based program
OptimizeRx Corporation (NASDAQ:OPRX) Q1 2024 Earnings Conference Call on May 14, 2024 at 2:30 PM ET with Company Participants including CEO William Febbo, CFO Edward Stelmakh, President Steve Silvestro, and SVP of Corporate Finance Andrew D'Silva. Various conference call participants are also present. Thank you for joining the discussion on OptimizeRx's First Quarter Fiscal 2024 Earnings.
The average price target suggests a potential 34.8% increase for OptimizeRx (OPRX). Although studies show this metric may not always be accurate, an increase in earnings estimates could indicate a positive outlook for the stock in the short term.
WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a top provider of healthcare technology solutions assisting life sciences companies in connecting with healthcare professionals (HCPs) and patients, disclosed today that its management will be attending the following upcoming investor conferences:
WALTHAM, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences:
OptimizeRx Corp. (OPRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
What type of business is OptimizeRx?
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.
What sector is OptimizeRx in?
OptimizeRx is in the Healthcare sector
What industry is OptimizeRx in?
OptimizeRx is in the Health Information Services industry
What country is OptimizeRx from?
OptimizeRx is headquartered in United States
When did OptimizeRx go public?
OptimizeRx initial public offering (IPO) was on 28 November 2007
What is OptimizeRx website?
https://www.optimizerx.com
Is OptimizeRx in the S&P 500?
No, OptimizeRx is not included in the S&P 500 index
Is OptimizeRx in the NASDAQ 100?
No, OptimizeRx is not included in the NASDAQ 100 index
Is OptimizeRx in the Dow Jones?
No, OptimizeRx is not included in the Dow Jones index
When was OptimizeRx the previous earnings report?
No data
When does OptimizeRx earnings report?
The next expected earnings date for OptimizeRx is 28 March 2025